Back to the search results

Johanna-Etienne-Krankenhaus

Johanna-Etienne-Krankenhaus
Johanna-Etienne-Krankenhaus

Am Hasenberg 46
41462 Neuss

Phone: 02131-529500
Fax: 02131-52959999
Mail: ed.suahneknark-enneite-annahoj@ofni

https://www.johanna-etienne-krankenhaus.de/
  • Number of beds: 415
  • Number of specialist departments: 8
  • Number of inpatient cases: 17.812
  • Number of outpatient cases: 37.000
  • Hospital owners: St. Augustinus Gruppe
  • Type of provider: freigemeinnützig
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
Brustkrebs

Seit vielen Jahren beteiligt sich das Brustzentrum Rhein-Kreis Neuss am Disease-Management-Programm (DMP) für Brustkrebs. Dieses Programm garantiert eine abgestimmte und kontinuierliche Betreuung der betroffenen Frauen gemeinsam mit den niedergelassenen Frauenärzten.

Quantity performed 62
Exception? No exception
Quantity performed 1
Exception? No exception
Quantity performed 19
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 62
Quantity forecast year: 94
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 360
Quantity forecast year: 380
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: no
Quantity performed reporting year: 1
Quantity forecast year: 0
Examination by state associations? no
Exemption? no
Result of the examination by the federal state authorities? no
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 47
Quantity forecast year: 53
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 19
Quantity forecast year: 23
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
127 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
70 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
70 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • Measures
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Patienteninformation Gespräch zu Ihren Medikamenten

21.06.2021

Risikostrategie (AK) / Qualitätspolitik und SOP`s im Bereich Qualitäts- und Risikomanagement

01.07.2023

Checkliste Arzneitherapie im Krankenhaus

21.09.2021

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Zentrale Stelldienste durch Fachpersonal
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Sonstige_elektronische_Unterstuetzung
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Zentraler Stelldienst - Stationsbegehung durch den Apotheker (Audits) - Interne Audits durch das Qualitätsmanagement (Prozessaudit AMTS)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
  • Ansprechpartner bei Rückfragen in der Klinik
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Training in other healing professions
Comment

Comment

Comment

Comment

Comment

Mitarbeiter der Savita GmbH

Comment

Mitarbeiter der Savita GmbH

Comment

Comment

Mitarbeiter der Savita GmbH

Comment

Praktische Einsätze

Comment

Comment

Comment

Comment

Helmut Schulz

Unterstützung der Patienten

Am Hasenberg 46
41462 Neuss

Phone: 02131 -529500-
Mail: ed.suahneknark-enneite-annahoj@ofni

Barbara Hagemann

MA JEK und MZEB

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52979798-
Mail: ed.ssuen-ka@nnamegah.b

Barbara Hagemann

MA JEK und MZEB

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52979798-
Mail: ed.ssuen-ka@nnamegah.b

Lukas Matyschik

Leitung Qualitäts- und Risikomanagement

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52979790-
Mail: ed.ssuen-ka@kihcsytam.l

Prof. Dr. med. Matthias Korell

Ärztlicher Direktor

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52955102-
Mail: ed.ssuen-ka@llerok.m

Prof. Dr. med. Matthias Korell

Ärztlicher Direktor

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52955102-
Mail: ed.ssuen-ka@llerok.m

Prof. Dr. Matthias Korell

Ärztlicher Direktor

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52955044-
Mail: ed.ssuen-ka@llerok.m

Barbara Hagemann

Projektmanagerin im MZEB (Medizinisches Zentrum für Erwachsene mit Behinderung)

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52979788-
Mail: ed.ssuen-ka@bezm

Am Hasenberg 46
41462 Neuss

Phone: 02131-529500
Fax: 02131-52959999
Mail: ed.suahneknark-enneite-annahoj@ofni

B.S. Anna Turczynski

Pflegedienstleitung

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52959100-
Mail: ed.ssuen-ka@iksnyzcrut.a

Diplom Kaufmann Sebastian Baum

Geschäftsführer

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52959992-
Mail: ed.suahneknark-enneite-annahoj@ofni

Diplom Kaufmann Sebastian Baum

Geschäftsführer

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52959992-
Mail: ed.suahneknark-enneite-annahoj@ofni

Sebastian Baum

Geschäftsführer

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52959990-
Mail: ed.suahneknark-enneite-annahoj@ofni

Sebastian Baum

Geschäftsführer

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52959990-
Mail: ed.suahneknark-enneite-annahoj@ofni

Prof. Matthias Korell

Ärztlicher Direktor

Am Hasenberg 46
41462 Neuss

Phone: 02131 -52955044-
Mail: ed.ssuen-ka@llerok.m

No

IK: 260511280

Location number: 771507000

Old location number: 771507000

Hospital portrait for download